Latest Growth Strategy News

ParagonCare appoints Carmen Riley as CEO effective July 1, 2025, with a planned transition period under outgoing CEO David Collins to complete integration and pursue M&A opportunities.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

archTIS Limited addresses ASX concerns over a sharp rise in its share price, linking the movement to recent contract wins in major defence markets and ongoing acquisition talks in the US.

Adherium Limited is raising up to $4 million through a partially underwritten entitlement offer to expand its US digital health platform and recruit key personnel. The capital raise supports scaling patient onboarding and advancing its FDA-cleared smart inhaler technology.

AIC Mines has secured $55 million through a well-supported placement to fund major expansions at its Eloise mine and the development of the Jericho copper project, backed by strategic investor Hawke’s Point.

Andean Silver’s latest drilling at the Cerro Bayo Project in Chile reveals extensive new high-grade silver and gold mineralisation outside current resources, bolstering its restart and growth strategy.

Vulcan Steel has extended the relaxation of its banking covenant thresholds through June 2026, reinforcing its liquidity position amid uncertain economic conditions.

Infragreen Group Limited has launched a $40 million initial public offering to accelerate growth in sustainable infrastructure across Australia and New Zealand, while strengthening its balance sheet through significant debt repayment.

Greatland Resources Limited is set to list on the ASX following a corporate reorganisation, showcasing robust production at its Telfer gold-copper mine and advancing development at the Havieron project.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

AGP Investment Management forecasts a strong unfranked distribution for the WCM Quality Global Growth Fund – Active ETF, following a stellar 30.22% return year-to-date that outpaces its benchmark by over 14%.

The Calmer Co. International Limited has launched its Taki Mai kava tinctures on Amazon USA, marking a strategic expansion into a rapidly growing wellness segment. This move aims to capitalize on the booming US tincture market and strengthen the company’s foothold in natural relaxation products.